2022-RA-959-ESGO Pelvic sentinel lymph nodedistribution; the final outcome of the Sentix trial (CEEGOG-CX01; ENGOT-CX2; NCT02494063) | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Cervical cancer

2022-RA-959-ESGO Pelvic sentinel lymph nodedistribution; the final outcome of the Sentix trial (CEEGOG-CX01; ENGOT-CX2; NCT02494063)

Free

Online download statistics by month:

Online download statistics by month: October 2022 to December 2023

	Abstract	Full	Pdf
Oct 2022	31	0	8
Nov 2022	51	0	11
Dec 2022	56	0	10
Jan 2023	45	0	7
Feb 2023	32	0	8
Mar 2023	76	0	16
Apr 2023	50	0	9
May 2023	39	0	8
Jun 2023	36	0	5
Jul 2023	54	0	8
Aug 2023	78	0	19
Sep 2023	48	0	9
Oct 2023	54	0	11
Nov 2023	82	0	17
Dec 2023	23	0	4
Total	755	0	150